Is CD133 mRNA Expression a Prognostic Factor in Colorectal Cancer?

被引：1
|
作者：
Hayama, Tamuro [1 ]
Watanabe, Toshiaki [1 ]
Iinuma, Hisae [1 ]
机构：
[1] Teikyo Univ, Sch Med, Dept Surg, Itabashi Ku, Tokyo 1738605, Japan
来源：
JOURNAL OF SURGICAL ONCOLOGY | 2011年 / 104卷 / 01期
关键词：
SURVIVAL;
D O I：
10.1002/jso.21895
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：110 / 110
页数：1
相关论文
共 50 条
  • [41] Expression of CD133 in SW620 colorectal cancer cells is modulated by the microenvironment
    Yang, Zhili
    Wang, Zhigang
    Fan, Youben
    Zheng, Qi
    ONCOLOGY LETTERS, 2012, 4 (01) : 75 - 79
  • [42] Differential Expression of CD133 Based on Microsatellite Instability Status in Human Colorectal Cancer
    Park, Jae Jun
    Kwon, Ji-hee
    Oh, Sun-Hee
    Choi, Junjeong
    Moon, Chang Mo
    Ahn, Joong Bae
    Hong, Sung Pil
    Cheon, Jae Hee
    Kim, Tae Il
    Kim, Hoguen
    Kim, Won Ho
    MOLECULAR CARCINOGENESIS, 2014, 53 : E1 - E10
  • [43] ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
    Czeczko, Leticia Elizabeth Augustin
    Ribas, Carmen Australia Paredes Marcondes
    Czeczko, Nicolau Gregori
    Skare, Thelma Larocca
    Yamakawa, Camila Kienen
    Gionedis, Guilherme
    Vasconcelos, Cecilia
    Bremer, Fabiola Pabst
    Castoldi, Diogo Francesco
    Gasser, Martin
    Waaga-Gasser, Ana Maria
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2021, 34 (02): : e1585
  • [44] ARE STEM CELL MARKER EXPRESSION AND CD133 ANALYSIS RELEVANT TO DIFFERENTIATE COLORECTAL CANCER?
    Augustin Czeczko, Leticia Elizabeth
    Paredes Marcondes Ribas, Carmen Australia
    Czeczko, Nicolau Gregori
    Skare, Thelma Larocca
    Yamakawa, Camila Kienen
    Gionedis, Guilherme
    Vasconcelos, Cecilia
    Bremer, Fabiola Pabst
    Castoldi, Diogo Francesco
    Gasser, Martin
    Waaga-Gasser, Ana Maria
    ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, 2020, 33 (04):
  • [45] Mutations in the Ras-Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
    Kemper, Kristel
    Versloot, Miranda
    Cameron, Katherine
    Colak, Selcuk
    de Sousa e Melo, Felipe
    de Jong, Joan H.
    Bleackley, Joanne
    Vermeulen, Louis
    Versteeg, Rogier
    Koster, Jan
    Medema, Jan Paul
    CLINICAL CANCER RESEARCH, 2012, 18 (11) : 3132 - 3141
  • [46] Expression of CD133, E-cadherin and WWOX in colorectal cancer and related analysis
    Sun, Wenwen
    Dou, Jinxia
    Zhang, Lin
    Qiao, Likui
    Shen, Na
    Gao, Wenyuan
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2017, 33 (02) : 425 - 429
  • [47] Augmented CD133 expression in distal margin correlates with poor prognosis in colorectal cancer
    Pradhan, Tapas
    Padmanabhan, Krishnanand
    Prasad, Manu
    Chandramohan, K.
    Nair, S. Asha
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) : 3984 - 3994
  • [48] CD133 Expression and the Prognosis of Colorectal Cancer: A Systematic Review and Meta-Analysis
    Chen, Shicai
    Song, Xinming
    Chen, Zhihui
    Li, Xinxin
    Li, Mingzhe
    Liu, Haiying
    Li, Jianchang
    PLOS ONE, 2013, 8 (02):
  • [49] Cytoplasmic CD133 expression correlates with histologic differentiation and is a significant prognostic factor in extrahepatic bile duct cancer and gallbladder cancer
    Mizukami, Tatsuzo
    Kamachi, Hirofumi
    Mitsuhashi, Tomoko
    Einama, Takahiro
    Hatanaka, Yutaka
    Kamiyama, Toshiya
    Taketomi, Akinobu
    ONCOLOGY LETTERS, 2018, 16 (05) : 6423 - 6430
  • [50] Prognostic impact of the expression of cancer stem cell markers CD166, CD44, EpCAM, ALDH1 and CD133 in colorectal cancer
    lezzi, Giandomenica
    Lugli, Alessandro
    Muraro, Manuele G.
    Mele, Valentina
    Hostettler, Isabel
    Tornillo, Luigi
    Carafa, Vincenza
    Spagnoli, Giulio C.
    Terracciano, Luigi
    Zlobec, Intl
    CANCER RESEARCH, 2010, 70
12345